Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-134774

Published: 2020

Journal Articles

Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-134303

Published: 2020

Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Blood (2019) 134 (Supplement_1): 2687.

https://doi.org/10.1182/blood-2019-131733

Published: 2019

Journal Articles

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

Michaela Kotrova, MD, Vincent H.J. van der Velden, PhD, Jacques J.M. van Dongen, MD PhD, Renata Formankova, MD PhD, Petr Sedlacek, MD PhD, Monika Brüggemann, MD PhD, Jan Zuna, MD PhD, Jan Stary, MD, Jan Trka, MD PhD, Eva Fronkova, M. D., Ph. D.

Blood (2016) 128 (22): 3494.

https://doi.org/10.1182/blood.V128.22.3494.3494

Published: 2016

Journal Articles

Euroflow-Based Immunophenotypic Characterization of CD34+ Cell Compartment in Juvenile Myelomonocytic Leukemia (JMML): A New Tool for Differential Diagnosis

Giuseppe Gaipa, PhD, Cristina Bugarin, Sergio Matarraz, Chiara Buracchi, PhD, Lukasz Sedek, MDPhD, Vincent H.J. van der Velden, PhD, Tomasz Szczepanski, Prof MD PhD, Alita van der Sluijs, Elaine Sobral da Costa, Michaela Novakova, Ester Mejstrikova, MD PhD, Carmen Aanei, Jacques JM van Dongen, Andrea Biondi, MD, Alberto Orfao, MD PhD

Blood (2016) 128 (22): 3127.

https://doi.org/10.1182/blood.V128.22.3127.3127

Published: 2016

Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD

Blood (2016) 128 (22): 2072.

https://doi.org/10.1182/blood.V128.22.2072.2072

Published: 2016

Journal Articles

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Blood (2016) 128 (22): 985.

https://doi.org/10.1182/blood.V128.22.985.985

Published: 2016

Journal Articles

The Relevance of Stem Cell Load at Diagnosis for the Development of Relapse in Pediatric Acute Myeloid Leukemia

Dirkje W. Hanekamp, Barbara Denys, Gertjan J.L. Kaspers, MD PhD, Jeroen G. te Marvelde, Gerrit Jan Schuurhuis, PhD, Valerie De Haas, MD PhD, Barbara De Moerloose, MD PhD, Eveline S. de Bont, Anja de Jong, Jan Philippé, MD PhD, Jacqueline Cloos, PhD, Vincent H.J. van der Velden, PhD

Blood (2015) 126 (23): 2584.

https://doi.org/10.1182/blood.V126.23.2584.2584

Published: 2015

Journal Articles

The Integrated Immunological Signature of Refractory Cytopenia of Childhood (RCC)

Demi de Winter, Marry M van den Heuvel-Eibrink, MD PhD, Vincent H.J. van der Velden, PhD, Anton W. Langerak, Jacques J.M. Dongen, Michael Dworzak, MD, Barbara De Moerloose, MD PhD, Jan Starý, MD, Charlotte M Niemeyer, MD PhD, Franco Locatelli, MD, Henrik Hasle, MD, Markus Schmugge, MD, C. Michel Zwaan, MD PhD, Rob Pieters, MD PhD

Blood (2015) 126 (23): 1657.

https://doi.org/10.1182/blood.V126.23.1657.1657

Published: 2015

Journal Articles

Bone Marrow Immunophenotyping By Flow Cytometry in Refractory Cytopenia of Childhood

Anna M. Aalbers, Marry M. van den Heuvel-Eibrink, Irith Baumann, Michael Dworzak, MD, Henrik Hasle, MD, Franco Locatelli, Barbara De Moerloose, Markus Schmugge, Ester Mejstrikova, MD, PhD, Michaela Novakova, Marco Zecca, MD, C. Michel Zwaan, Jeroen G. te Marvelde, Anton W Langerak, Jacques J.M. van Dongen, Rob Pieters, Charlotte Niemeyer, Vincent H.J. van der Velden, PhD

Blood (2014) 124 (21): 1916.

https://doi.org/10.1182/blood.V124.21.1916.1916

Published: 2014

Journal Articles

Extensive Molecular Analysis Strongly Improves the Distinction Between AML and ALL in Adult Acute Leukemias of Ambiguous Lineage

Aniko Szabo, MD, Mathijs A. Sanders, MSc, Carla Exalto, Jasper E. Koenders, Patricia G. Hoogeveen, Anita M. Schelen, Willemijn van den Ancker, MD MSc, PhD, Arjan A. van de Loosdrecht, MD PhD, Bob Lowenberg, MD PhD, Vincent H.J. van der Velden, PhD, Jan J. Cornelissen, MD PhD, Peter J.M. Valk, PhD, Anita W. Rijneveld, MD PhD

Blood (2014) 124 (21): 1067.

https://doi.org/10.1182/blood.V124.21.1067.1067

Published: 2014

Journal Articles

Recovery of the Normal B-Cell Compartment in Children Treated for B-Cell Precursor Acute Lymphoblastic Leukemia

Prisca Theunissen, Ester Mejstrikova, MD, PhD, Tomasz Szczepanski, MD PhD, Lukasz Sedek, PhD, Alita van der Sluijs, Alberto Orfao, MD PhD, Jacques JM van Dongen, MD PhD, Vincent H.J. van der Velden, PhD

Blood (2014) 124 (21): 3792.

https://doi.org/10.1182/blood.V124.21.3792.3792

Published: 2014

Journal Articles

Immunophenotyping Versus Morphological Evaluation Of Fresh and Stabilized Cerebrospinal Fluid As Diagnostic Tool For CNS Involvement In Childhood Acute Lymphoblastic Leukemia

Edwin Sonneveld, PhD, Christian M. Zwaan, MD, PhD, Alita J van der Sluijs-Gelling, Valerie de Haas, MD, PhD, Rob Pieters, Vincent H.J. van der Velden, PhD

Blood (2013) 122 (21): 4950.

https://doi.org/10.1182/blood.V122.21.4950.4950

Published: 2013

Journal Articles

Proteomic Exploration of the Cell Surface Landscape Reveals New Leukemia Associated Features.

Jean-Pierre Bourquin, MD, PhD, Paulina Mirkowska, MSc, Ester Mejstrikova, Lucie Slamova, MD, Tomasz Szczepanski, MD, PhD, Lukasz Sedek, PhD, Maike Schmitz, PhD, Vincent H.J. van der Velden, PhD, Andreas Hofmann, PhD, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Beat C Bornhauser, PhD, Bernd Wollscheid, PhD

Blood (2012) 120 (21): 2506.

https://doi.org/10.1182/blood.V120.21.2506.2506

Published: 2012

Journal Articles

Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia

Arian Van Der Veer, Esmee Waanders, PhD, Rob Pieters, MD, PhD, Marieke E. Willemse, Simon Reijmersdaal, Lisa J Russell, PhD, Christine J Harrison, PhD, FRCPath, William E. Evans, PharmD, Vincent H.J. van der Velden, PhD, Peter M. Hoogerbrugge, Frank N. van Leeuwen, PhD, G. Escherich, Martin Horstman, Leila mohammadi Khankahdani, Dimitris Rizopoulos, Hester A. de Groot-Kruseman, PhD, Edwin Sonneveld, PhD, Roland P. Kuiper, PhD, Monique L. Den Boer, PhD

Blood (2012) 120 (21): 880.

https://doi.org/10.1182/blood.V120.21.880.880

Published: 2012

Journal Articles

Human Telomere Disease Due to Disruption of the CCAAT Box of the TERC Promoter

Anna M. Aalbers, MD, Sachiko Kajigaya, PhD, Vincent H.J. van der Velden, PhD, Marry M. van den Heuvel-Eibrink, M.D., Rodrigo T. Calado, MD, PhD, Neal S. Young, MD

Blood (2011) 118 (21): 2405.

https://doi.org/10.1182/blood.V118.21.2405.2405

Published: 2011

Journal Articles

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Blood (2011) 118 (21): 2535.

https://doi.org/10.1182/blood.V118.21.2535.2535

Published: 2011

Journal Articles

Exome Sequencing of Late Recurrence T-Cell Acute Lymphoblastic Leukemia in Children Confirms Second Leukemia and Exposes Predisposition Candidate Genes

Esmé Waanders, PhD, Vincent H.J. van der Velden, PhD, Tomasz Szczepanski, Lisenka E.L.M. Vissers, PhD, Joep de Ligt, MSc, Christian Gilissen, Anke A.H. van Dijk, BSc, Simon V. van Reijmersdal, BSc, Peter M. Hoogerbrugge, MD, PhD, Ad Geurts van Kessel, PhD, Jacques J.M. van Dongen, PhD, Roland P. Kuiper, PhD

Blood (2011) 118 (21): 755.

https://doi.org/10.1182/blood.V118.21.755.755

Published: 2011

Journal Articles

Deletion of IKZF1 in Pediatric Precursor-B ALL Is a Strong Prognostic Marker for Relapse.

Roland P. Kuiper, PhD, Esmee Waanders, PhD, Vincent H.J. Van der Velden, PhD, Simon V van Reijmersdal, Blanca Scheijen, PhD, Jayne Hehir-Kwa, Suzanne T.M. Keijzers-Vloet, Edwin Sonneveld, PhD, Jacques JM van Dongen, Ph.D, Frank N. van Leeuwen, PhD, Ad Geurts van Kessel, Peter M. Hoogerbrugge

Blood (2009) 114 (22): 1104.

https://doi.org/10.1182/blood.V114.22.1104.1104

Published: 2009

Journal Articles

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Tomasz Szczepanski, MD, PhD, Vincent H.J. van der Velden, PhD, Pieter Van Vlierberghe, Bernd Gruhn, MD, PhD, Renate Panzer-Grumayer, MD, PhD, Monica Spinelli, Helene Cave, PhD, Udo zur Stadt, PhD, Dario Campana, MD, PhD, Andre Schrauder, MD, PhD, Elisabeth van Wering, PhD, Jules P.P. Meijerink, PhD, Jacques J.M. van Dongen, MD, PhD

Blood (2007) 110 (11): 1435.

https://doi.org/10.1182/blood.V110.11.1435.1435

Published: 2007

NARROW

A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study

Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

Euroflow-Based Immunophenotypic Characterization of CD34+ Cell Compartment in Juvenile Myelomonocytic Leukemia (JMML): A New Tool for Differential Diagnosis

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

The Relevance of Stem Cell Load at Diagnosis for the Development of Relapse in Pediatric Acute Myeloid Leukemia

The Integrated Immunological Signature of Refractory Cytopenia of Childhood (RCC)

Bone Marrow Immunophenotyping By Flow Cytometry in Refractory Cytopenia of Childhood

Extensive Molecular Analysis Strongly Improves the Distinction Between AML and ALL in Adult Acute Leukemias of Ambiguous Lineage

Recovery of the Normal B-Cell Compartment in Children Treated for B-Cell Precursor Acute Lymphoblastic Leukemia

Immunophenotyping Versus Morphological Evaluation Of Fresh and Stabilized Cerebrospinal Fluid As Diagnostic Tool For CNS Involvement In Childhood Acute Lymphoblastic Leukemia

Proteomic Exploration of the Cell Surface Landscape Reveals New Leukemia Associated Features.

Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia

Human Telomere Disease Due to Disruption of the CCAAT Box of the TERC Promoter

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

Exome Sequencing of Late Recurrence T-Cell Acute Lymphoblastic Leukemia in Children Confirms Second Leukemia and Exposes Predisposition Candidate Genes

Deletion of IKZF1 in Pediatric Precursor-B ALL Is a Strong Prognostic Marker for Relapse.

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only